SignatureFD’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.3K | Sell |
5,947
-235
| -4% | -$2.11K | ﹤0.01% | 1546 |
|
|
2025
Q1 | $46.4K | Sell |
6,182
-507
| -8% | -$3.8K | ﹤0.01% | 1606 |
|
|
2024
Q4 | $50.3K | Buy |
6,689
+384
| +6% | +$2.89K | ﹤0.01% | 1575 |
|
|
2024
Q3 | $47.9K | Sell |
6,305
-293
| -4% | -$2.23K | ﹤0.01% | 1590 |
|
|
2024
Q2 | $40.8K | Buy |
6,598
+5,599
| +560% | +$34.6K | ﹤0.01% | 1612 |
|
|
2024
Q1 | $5.08K | Sell |
999
-684
| -41% | -$3.48K | ﹤0.01% | 2532 |
|
|
2023
Q4 | $10.1K | Buy |
1,683
+910
| +118% | +$5.45K | ﹤0.01% | 2248 |
|
|
2023
Q3 | $5.47K | Buy |
+773
| New | +$5.47K | ﹤0.01% | 2451 |
|
|
2023
Q2 | – | Sell |
-93
| Closed | -$776 | – | 3234 |
|
|
2023
Q1 | $776 | Buy |
+93
| New | +$776 | ﹤0.01% | 3036 |
|
|
2022
Q4 | – | Sell |
-14
| Closed | – | – | 3292 |
|
|
2022
Q3 | $0 | Buy |
+14
| New | – | ﹤0.01% | 3101 |
|
|
2022
Q2 | – | Sell |
-33
| Closed | -$1K | – | 3105 |
|
|
2022
Q1 | $1K | Buy |
+33
| New | +$1K | ﹤0.01% | 2939 |
|